Sumpo, Socrates R.
HRN: 27-03-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/26/2025
05/03/2025
IV
600mg
Q6
Diabetic Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes